Can-Fite BioPharma CANF
NYSE CANF
$1.80 -0.05 (-2.70%)
At close: Oct 23, 2026 · 4:00 PM EDT

Can-Fite BioPharma (CANF) Purchase of Investments (2017 - 2018)

Updated

Analysis

Can-Fite BioPharma (CANF) Purchase of Investments (2017 - 2018) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Purchased (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 307.00 Mn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 919.00 Mn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 834.00 Mn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 148.00 Mn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 46.00 Mn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 42.00 Mn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 2.54 Bn
10 Can-Fite BioPharma 2.36 Mn -17.35 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2018 1.83 Mn
Dec 31, 2017 917,000.00
API Access

Can-Fite BioPharma Purchase of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=purchase-of-investments&ticker=CANF&period=max&api_key=YOUR_API_KEY